• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清细胞角蛋白-18与非酒精性脂肪肝患者中NOX2产生的氧化应激相关。

Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver.

作者信息

Del Ben M, Polimeni L, Baratta F, Bartimoccia S, Carnevale R, Loffredo L, Pignatelli P, Violi F, Angelico F

机构信息

Department of Internal Medicine and Medical Specialities, Sapienza University, Rome, Italy.

Department of Internal Medicine and Medical Specialities, Sapienza University, Rome, Italy ; Department of Public Health and Infectious Disease, Sapienza University, Rome, Italy.

出版信息

Int J Hepatol. 2014;2014:784985. doi: 10.1155/2014/784985. Epub 2014 Jan 29.

DOI:10.1155/2014/784985
PMID:24678423
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3941779/
Abstract

Background & Aims. Hepatocyte apoptosis may play a role in progression of nonalcoholic fatty liver and oxidative stress seems one of the key mechanisms responsible for liver damage. The aim was to determine the association of oxidative stress with cytokeratin-18 M30 fragment levels, a marker of hepatocyte apoptosis. Methods. Steatosis severity was defined according to Hamaguchi's echographic criteria in 209 patients with nonalcoholic fatty liver. Serum cytokeratin-18, urinary 8-iso-prostaglandin F2 α , soluble NOX2-derived peptide, and adiponectin were measured. Results. Serum cytokeratin-18 progressively increased with steatosis severity (from 169.5 (129.3/183.8) to 176 (140/190) and 180 (169.5/192.5) μ IU/mL in mild, moderate, and severe steatosis, respectively; P < 0.01). After stratification by cytokeratin-18 tertiles, a significant progression of body mass index, HOMA-IR, triglycerides, urinary 8-iso-PGF2 α , soluble NOX2-derived peptide, and of the prevalence of diabetes and severe steatosis was found, while HDL-cholesterol and adiponectin progressively decreased. A positive correlation between cytokeratin-18 and body mass index, HOMA-IR, Hamaguchi's score, urinary 8-iso-PGF2 α , and soluble NOX2-derived peptide and a negative correlation between cytokeratin-18 and HDL-cholesterol and adiponectin were found. Body mass index, adiponectin, and soluble NOX2-derived peptide were independent predictors of serum cytokeratin-18 levels (adjusted R (2) = 0.36). Conclusion. We support an association between oxidative stress and severity of liver damage in patients with nonalcoholic fatty liver.

摘要

背景与目的。肝细胞凋亡可能在非酒精性脂肪性肝病进展中起作用,氧化应激似乎是导致肝损伤的关键机制之一。本研究旨在确定氧化应激与细胞角蛋白18 M30片段水平(肝细胞凋亡标志物)之间的关联。方法。根据滨口超声标准对209例非酒精性脂肪性肝病患者的脂肪变性严重程度进行定义。检测血清细胞角蛋白18、尿8-异前列腺素F2α、可溶性NOX2衍生肽和脂联素。结果。血清细胞角蛋白18水平随脂肪变性严重程度逐渐升高(轻度、中度和重度脂肪变性患者分别为169.5(129.3/183.8)、176(140/190)和180(169.5/192.5)μIU/mL;P<0.01)。按细胞角蛋白18三分位数分层后,发现体重指数、HOMA-IR、甘油三酯、尿8-异前列腺素F2α、可溶性NOX2衍生肽以及糖尿病和重度脂肪变性患病率显著升高,而高密度脂蛋白胆固醇和脂联素逐渐降低。发现细胞角蛋白18与体重指数、HOMA-IR、滨口评分、尿8-异前列腺素F2α和可溶性NOX2衍生肽呈正相关,与高密度脂蛋白胆固醇和脂联素呈负相关。体重指数、脂联素和可溶性NOX2衍生肽是血清细胞角蛋白18水平的独立预测因素(调整后R(2)=0.36)。结论。我们支持非酒精性脂肪性肝病患者氧化应激与肝损伤严重程度之间存在关联。

相似文献

1
Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver.血清细胞角蛋白-18与非酒精性脂肪肝患者中NOX2产生的氧化应激相关。
Int J Hepatol. 2014;2014:784985. doi: 10.1155/2014/784985. Epub 2014 Jan 29.
2
NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease.NOX2产生的氧化应激与非酒精性脂肪性肝病患者肝脏超声脂肪变性的严重程度相关。
BMC Gastroenterol. 2014 Apr 23;14:81. doi: 10.1186/1471-230X-14-81.
3
Does Nox2 Overactivate in Children with Nonalcoholic Fatty Liver Disease?非酒精性脂肪性肝病患儿中 Nox2 是否过度激活?
Antioxid Redox Signal. 2019 Apr 1;30(10):1325-1330. doi: 10.1089/ars.2018.7596. Epub 2018 Aug 17.
4
Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.非酒精性脂肪性肝病患者的脂肪细胞因子和细胞角蛋白-18:CHA 指数的引入。
Ann Hepatol. 2013 Sep-Oct;12(5):749-57.
5
Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population.瘦素/脂联素比值与日本人群非酒精性脂肪性肝病的肝脂肪变性相关,但与动脉僵硬度无关。
Cytokine. 2020 Feb;126:154927. doi: 10.1016/j.cyto.2019.154927. Epub 2019 Nov 27.
6
Irisin in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的鸢尾素。
Metabolism. 2014 Feb;63(2):207-17. doi: 10.1016/j.metabol.2013.09.013. Epub 2013 Oct 18.
7
The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes.健康受试者口服葡萄糖负荷后急性高血糖会引起可溶性 CD26/二肽基肽酶 4 血清水平升高,与高分子量脂联素和肝酶有关。
Transl Res. 2013 Nov;162(5):309-16. doi: 10.1016/j.trsl.2013.07.011. Epub 2013 Aug 30.
8
Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis.细胞角蛋白18胞外可溶性形式可区分单纯性脂肪变性与非酒精性脂肪性肝炎。
World J Gastroenterol. 2007 Feb 14;13(6):837-44. doi: 10.3748/wjg.v13.i6.837.
9
M30 does not predict the severity of hepatosteatosis, whereas adiponectin level declined with increase of ALT and the severity of hepatic steatosis.M30不能预测肝脂肪变性的严重程度,而脂联素水平随谷丙转氨酶升高及肝脂肪变性严重程度增加而下降。
J Clin Lab Anal. 2014 Sep;28(5):381-5. doi: 10.1002/jcla.21697. Epub 2014 Mar 19.
10
How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.在普通人群中,控制衰减参数和脂肪肝指数评估肝脂肪变性的效果如何:与超声的相关性
Liver Int. 2014 Jul;34(6):e111-7. doi: 10.1111/liv.12305. Epub 2013 Sep 4.

引用本文的文献

1
Exogenous HS reduces oxidative stress induced by lipid mixture in HepG2 cells through USP22/SIRT1 axis.外源性透明质酸通过USP22/SIRT1轴减轻脂质混合物在HepG2细胞中诱导的氧化应激。
Sci Rep. 2025 Jul 2;15(1):23129. doi: 10.1038/s41598-025-04924-2.
2
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.非酒精性脂肪性肝病或代谢相关脂肪性肝病患者 2 型糖尿病的全球流行病学:系统评价和荟萃分析。
BMC Med. 2024 Mar 6;22(1):101. doi: 10.1186/s12916-024-03315-0.
3
Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice.口服补充肠道微生物代谢产物吲哚-3-乙酸可缓解小鼠饮食诱导的脂肪变性和炎症。
Elife. 2024 Feb 27;12:RP87458. doi: 10.7554/eLife.87458.
4
Investigating the Efficacy of in Metabolic Syndrome Treatment: A Narrative Review of What Is Known So Far.探讨 治疗代谢综合征的疗效:迄今为止已知内容的叙述性综述。
Int J Mol Sci. 2023 Jul 27;24(15):12015. doi: 10.3390/ijms241512015.
5
Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC.2 型糖尿病和肥胖症患者肝衰竭的代谢谱:从非酒精性脂肪性肝病到非酒精性脂肪性肝炎再到肝细胞癌。
Int J Mol Sci. 2021 Apr 26;22(9):4495. doi: 10.3390/ijms22094495.
6
New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress.非酒精性脂肪性肝病发病机制的新见解:肠道来源的脂多糖和氧化应激。
Nutrients. 2020 Sep 10;12(9):2762. doi: 10.3390/nu12092762.
7
Poor Adherence to Mediterranean Diet and Serum Lipopolysaccharide are Associated with Oxidative Stress in Patients with Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者对地中海饮食的依从性差和血清脂多糖与氧化应激有关。
Nutrients. 2020 Jun 10;12(6):1732. doi: 10.3390/nu12061732.
8
Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH.非酒精性脂肪性肝炎患者中 Vitronectin V10 亚单位的过表达:对 NASH 无创诊断的意义。
Int J Mol Sci. 2018 Feb 18;19(2):603. doi: 10.3390/ijms19020603.
9
Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility.肝脏线粒体DNA拷贝数和缺失水平可能与非酒精性脂肪性肝病易感性有关。
Hepat Mon. 2016 Nov 9;16(12):e40774. doi: 10.5812/hepatmon.40774. eCollection 2016 Dec.
10
Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis.氧化应激:非酒精性脂肪性肝病与动脉粥样硬化关联的新见解
World J Hepatol. 2015 Jun 8;7(10):1325-36. doi: 10.4254/wjh.v7.i10.1325.

本文引用的文献

1
Oxidative stress and inflammatory markers in relation to circulating levels of adiponectin.氧化应激和炎症标志物与脂联素循环水平的关系。
Obesity (Silver Spring). 2013 Jul;21(7):1467-73. doi: 10.1002/oby.20097. Epub 2013 Apr 13.
2
NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.非酒精性脂肪性肝病纤维化评分:用于预测非酒精性脂肪性肝病患者死亡和肝脏并发症的预后指标。
World J Gastroenterol. 2013 Feb 28;19(8):1219-29. doi: 10.3748/wjg.v19.i8.1219.
3
Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment.阻塞性睡眠呼吸暂停患者的氧化应激介导的动脉功能障碍及持续气道正压通气治疗的影响。
BMC Pulm Med. 2012 Jul 23;12:36. doi: 10.1186/1471-2466-12-36.
4
Obesity and hypercholesterolemia are associated with NOX2 generated oxidative stress and arterial dysfunction.肥胖和高胆固醇血症与 NOX2 产生的氧化应激和动脉功能障碍有关。
J Pediatr. 2012 Dec;161(6):1004-9. doi: 10.1016/j.jpeds.2012.05.042. Epub 2012 Jun 23.
5
Urinary biomarkers of oxidative status.尿液氧化应激生物标志物。
Clin Chim Acta. 2012 Oct 9;413(19-20):1446-53. doi: 10.1016/j.cca.2012.06.012. Epub 2012 Jun 7.
6
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.系统评价:成人非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学和自然史。
Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30.
7
Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome.在代谢综合征患者中,通过下调 NADPH 氧化酶 2 产生的氧化应激,体重减轻与改善内皮功能障碍有关。
Intern Emerg Med. 2012 Jun;7(3):219-27. doi: 10.1007/s11739-011-0591-x. Epub 2011 Apr 22.
8
Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.非酒精性脂肪性肝病患者血清脂联素水平:系统评价和荟萃分析。
Metabolism. 2011 Mar;60(3):313-26. doi: 10.1016/j.metabol.2010.09.003. Epub 2010 Oct 30.
9
Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients.阿托伐他汀通过脂联素介导的 NADPH 氧化酶下调抑制高胆固醇血症患者的氧化应激。
Atherosclerosis. 2010 Nov;213(1):225-34. doi: 10.1016/j.atherosclerosis.2010.08.056. Epub 2010 Aug 19.
10
Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia.阿托伐他汀抑制高胆固醇血症患者循环 gp91phox 水平。
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):360-7. doi: 10.1161/ATVBAHA.109.198622. Epub 2009 Dec 3.